- Home
- MRK vs HBANL Comparison
MRK vs HBANL Comparison
Compare MRK & HBANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | HBANL |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 20242 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | HBANL |
|---|---|---|
| Price | $100.03 | $25.72 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 15.2M | N/A |
| Earning Date | 02-03-2026 | N/A |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | N/A |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | $13.13 | ★ N/A |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | N/A |
| 52 Week High | $105.84 | N/A |
Technical Indicators
Market Signals| Indicator | MRK | HBANL |
|---|---|---|
| Relative Strength Index (RSI) | 58.32 | 56.16 |
| Support Level | $96.79 | $25.66 |
| Resistance Level | $100.94 | $25.85 |
| Average True Range (ATR) | 2.41 | 0.20 |
| MACD | -0.59 | 0.00 |
| Stochastic Oscillator | 43.38 | 59.10 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.